A-shares closed · 港股休市 Quotes 行情 · 25 Sep 17:19 CST
27 Sep 2026 · 22:05 CST Terminal Access 终端入口 →
300759.SZ深圳证券交易所 · 创业板 ChiNext

Pharmaron Beijing 康龙化成

Healthcare Services 医疗服务
¥43.50−¥1.52 · −3.38%Delayed 行情延迟 · 24 Sep 2026 · 16:14 CST · CNY
Open 开盘
¥44.52
High 最高
¥45.27
Low 最低
¥43.50
Prev Close 昨收
¥45.02
Volume 成交量
3,874.2万股
Turnover 成交额
¥17亿
Mkt Cap 总市值
¥799亿
P/E 市盈率
46.7×
Recent Activity 近期动态All Filings 全部公告 →

19 significant filings since 30 May 2026: 1 on share pledge, 7 on equity incentive and 3 on pledge released, and 5 other kinds. The latest, on 22 Sep 2026: 关于公司实际控制人的一致行动人部分股份解除质押的公告. On 13 Jul 2026 the company said it expects net profit for the period ending 30 Jun 2026 to rise by 4.00% to 10.00% from the same period a year earlier.
自 30 May 2026 起有 19 份重大公告:share pledge 1 份、equity incentive 7 份、pledge released 3 份,另有 5 类。最新一份(22 Sep 2026):关于公司实际控制人的一致行动人部分股份解除质押的公告。13 Jul 2026 公司预告截至 30 Jun 2026 的净利润较上年同期上升 4.00% 至 10.00%。

Price History 价格走势

1 session 个交易日, Thu 24 Sep 2026 · Live one-minute prices · High 最高 ¥45.15 · Low 最低 ¥43.50 · −3.38% on the previous close of ¥45.02
43.5043.7544.0044.2544.5044.7545.00
Volume 成交量
1.1万
09:3010:3011:3014:0015:00

Against Its Own History 与自身历史比较

46.7×
Median 中值 30.1× · Range 区间 25.4× to 41.7× · 7 periods 期
4.89×
Median 中值 3.30× · Range 区间 2.55× to 4.35× · 10 periods 期

Period by Period 逐期

Period 报告期Close at Period End 期末收盘TTM EPS 滚动每股收益 BPS 每股净资产
30 Jun 2026 中报¥28.93¥0.9630.1×¥8.903.25×
31 Mar 2026 一季报¥27.98¥0.9629.2×¥8.963.12×
31 Dec 2025 年报¥28.43¥0.9430.1×¥8.473.36×
30 Sep 2025 三季报¥35.75¥0.8641.7×¥8.224.35×
30 Jun 2025 中报¥24.54¥0.7831.3×¥8.023.06×
31 Mar 2025 一季报¥26.92¥1.0625.5×¥7.903.41×
31 Dec 2024 年报¥25.70¥1.0125.4×¥7.663.36×
30 Sep 2024 三季报¥30.35——¥7.494.05×
30 Jun 2024 中报¥18.58——¥7.282.55×
31 Mar 2024 一季报¥20.37——¥7.032.90×

Consensus Forward EPS 机构预测每股收益

Fiscal Year 年度EPS Median 中值Range 区间Brokers 机构数Forward P/E 预测市盈率
2026¥1.10¥1.06 to ¥1.20339.5×
2027¥1.47¥1.41 to ¥1.60329.6×
2028¥1.76¥1.75 to ¥2.05324.7×
Not Computed 未计算
  • Dividend Yield 股息率
  • Free Cash Flow 自由现金流
  • EV/EBITDA